Multiple Sclerosis

January 8, 2019

2019 Looks Brighter for MS

Welcome to 2019: a year that holds some exciting developments for multiple sclerosis medication choices. There are a number of new medications which have reached the […]
December 18, 2018

Put Down the Salt Shaker!

Multiple sclerosis is a complex autoimmune disease of the central nervous system which develops when the protective myelin sheath surrounding nerve cells is attacked by the […]
March 2, 2018

Biogen and AbbVie Announce the Voluntary Worldwide Withdrawal of Marketing Authorizations for ZINBRYTA® (daclizumab) for Relapsing Multiple Sclerosis

CAMBRIDGE, Mass. & NORTH CHICAGO, Ill.–(BUSINESS WIRE)–Biogen (Nasdaq:BIIB) and AbbVie (NYSE:ABBV) today announced the voluntary worldwide withdrawal of ZINBRYTA for relapsing multiple sclerosis. The companies believe that characterizing the complex and […]
December 18, 2017

Number of Multiple Sclerosis Patients in US Closer to 1 Million, NMSS Survey Finds

There are more Americans with multiple sclerosis than previously thought. An estimated 947,000 people in the U.S. have multiple sclerosis (MS) — more than double the […]
December 11, 2017

Ozanimod successful in clinical trials for multiple sclerosis

The medication ozanimod is showing good results in studies with multiple sclerosis. The findings from the two pivotal phase 3 (SUNBEAM and RADIANCE Part B) trials […]
November 17, 2017

Multiple Sclerosis Can Stay Mild for Decades, 30-year British Study Shows

Multiple sclerosis can progress very slowly for some patients. After the first round of symptoms, multiple sclerosis can stay mild without causing major problems for decades, a […]
November 13, 2017

Concussions in Teenagers Tied to Multiple Sclerosis Risk 

Head injuries might be linked to future multiple sclerosis risk. Here’s yet another reason to protect young athletes from head trauma: A large-scale new study found […]